Less commonly, dyspepsia, duodenitis, cholecystitis, pancreatitis, hepatitis, constipation, arrhythmias (including QT interval prolongation), syncope, raised serum cholesterol, hypersensitivity reactions (including flushing), ataxia, nystagmus, hypoesthesia, adrenocortical insufficiency, arthritis, blepharitis, optic neuritis, scleritis, glossitis, gingivitis, psoriasis, Stevens-Johnson syndrome.
Rarely, pseudomembranous colitis, taste disturbances (more common with oral suspension), convulsions, insomnia, tinnitus, hearing disturbances, extrapyramidal effects, hypertonia, hypothyroidism, hyperthyroidism, discoid lupus erythematosus, toxic epidermal necrolysis, pseudoporphyria, retinal hemorrhage, optic atrophy; also reported squamous cell carcinoma of skin (particularly in presence of phototoxicity or in the immunosuppressed).
View ADR Monitoring Form